iCLAS Continuous Lesion Ablation System

Device Adagio Medical, Inc.
Total Payments
$2.8M
Transactions
155
Doctors
11
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2024 $133,333 4 0
2023 $330,657 10 0
2022 $1.3M 77 9
2021 $1.1M 64 3

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $2.8M 141 99.9%
Consulting Fee $1,050 2 0.0%
Food and Beverage $579.96 12 0.0%

Payments by Type

Research
$2.8M
141 transactions
General
$1,630
14 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
iCLAS for Persistent Atrial Fibrillation Adagio Medical, Inc. $2.8M 0

Top Doctors Receiving Payments for iCLAS Continuous Lesion Ablation System

Doctor Specialty Location Total Records
Unknown Atlanta, GA $2.8M 141
, M.D Cardiovascular Disease Houston, TX $1,050 2
, MD Cardiovascular Disease Phoenix, AZ $148.86 2
, M.D Clinical Cardiac Electrophysiology Ridgewood, NJ $146.39 2
, M.D Clinical Cardiac Electrophysiology Phoenix, AZ $137.04 1
, M.D Clinical Cardiac Electrophysiology San Diego, CA $38.11 1
, MD Cardiovascular Disease Naperville, IL $18.26 1
, MD Cardiovascular Disease Naperville, IL $18.26 1
, MD Cardiovascular Disease Naperville, IL $18.26 1
, MD Internal Medicine Naperville, IL $18.26 1
, M.D Clinical Cardiac Electrophysiology Naperville, IL $18.26 1
, MD Internal Medicine Naperville, IL $18.26 1

About iCLAS Continuous Lesion Ablation System

iCLAS Continuous Lesion Ablation System is a device associated with $2.8M in payments to 11 healthcare providers, recorded across 155 transactions in the CMS Open Payments database. The primary manufacturer is Adagio Medical, Inc..

Payment data is available from 2021 to 2024. In 2024, $133,333 was paid across 4 transactions to 0 doctors.

The most common payment nature for iCLAS Continuous Lesion Ablation System is "Unspecified" ($2.8M, 99.9% of total).

iCLAS Continuous Lesion Ablation System is associated with 1 research study, including "iCLAS for Persistent Atrial Fibrillation" ($2.8M).